Literature DB >> 34898189

Analysis of Three Architectures for Controlling PTP1B with Light.

Akarawin Hongdusit1, Evan T Liechty1, Jerome M Fox1.   

Abstract

Photosensory domains are powerful tools for placing proteins under optical control, but their integration into light-sensitive chimeras is often challenging. Many designs require structural iterations, and direct comparisons of alternative approaches are rare. This study uses protein tyrosine phosphatase 1B (PTP1B), an influential regulatory enzyme, to compare three architectures for controlling PTPs with light: a protein fusion, an insertion chimera, and a split construct. All three designs permitted optical control of PTP1B activity in vitro (i.e., kinetic assays of purified enzyme) and in mammalian cells; photoresponses measured under both conditions, while different in magnitude, were linearly correlated. The fusion- and insertion-based architectures exhibited the highest dynamic range and maintained native localization patterns in mammalian cells. A single insertion architecture enabled optical control of both PTP1B and TCPTP, but not SHP2, where the analogous chimera was active but not photoswitchable. Findings suggest that PTPs are highly tolerant of domain insertions and support the use of in vitro screens to evaluate different optogenetic designs.

Entities:  

Keywords:  light-oxygen-voltage domains; optogenetics; protein engineering; protein tyrosine phosphatases; signaling

Mesh:

Substances:

Year:  2021        PMID: 34898189      PMCID: PMC8916241          DOI: 10.1021/acssynbio.1c00398

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  40 in total

1.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.

Authors:  Marcus Bantscheff; Dirk Eberhard; Yann Abraham; Sonja Bastuck; Markus Boesche; Scott Hobson; Toby Mathieson; Jessica Perrin; Manfred Raida; Christina Rau; Valérie Reader; Gavain Sweetman; Andreas Bauer; Tewis Bouwmeester; Carsten Hopf; Ulrich Kruse; Gitte Neubauer; Nigel Ramsden; Jens Rick; Bernhard Kuster; Gerard Drewes
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

2.  Small molecule gated split-tyrosine phosphatases and orthogonal split-tyrosine kinases.

Authors:  Karla Camacho-Soto; Javier Castillo-Montoya; Blake Tye; Luca O Ogunleye; Indraneel Ghosh
Journal:  J Am Chem Soc       Date:  2014-11-26       Impact factor: 15.419

Review 3.  Targeting Tyrosine Phosphatases: Time to End the Stigma.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Trends Pharmacol Sci       Date:  2017-04-12       Impact factor: 14.819

4.  Optical control of cell signaling by single-chain photoswitchable kinases.

Authors:  Xin X Zhou; Linlin Z Fan; Pengpeng Li; Kang Shen; Michael Z Lin
Journal:  Science       Date:  2017-02-24       Impact factor: 47.728

5.  Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP.

Authors:  Sandra Galic; Manuela Klingler-Hoffmann; Michelle T Fodero-Tavoletti; Michelle A Puryer; Tzu-Ching Meng; Nicholas K Tonks; Tony Tiganis
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 6.  PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.

Authors:  Sheng Zhang; Zhong-Yin Zhang
Journal:  Drug Discov Today       Date:  2007-04-06       Impact factor: 7.851

7.  Rapid blue-light-mediated induction of protein interactions in living cells.

Authors:  Matthew J Kennedy; Robert M Hughes; Leslie A Peteya; Joel W Schwartz; Michael D Ehlers; Chandra L Tucker
Journal:  Nat Methods       Date:  2010-10-31       Impact factor: 28.547

8.  PTPN22 inhibition resets defective human central B cell tolerance.

Authors:  Jean-Nicolas Schickel; Marcel Kuhny; Alessia Baldo; Jason M Bannock; Christopher Massad; Haowei Wang; Nathan Katz; Tyler Oe; Laurence Menard; Pauline Soulas-Sprauel; Till Strowig; Richard Flavell; Eric Meffre
Journal:  Sci Immunol       Date:  2016-07-22

9.  Optimized second-generation CRY2-CIB dimerizers and photoactivatable Cre recombinase.

Authors:  Amir Taslimi; Brian Zoltowski; Jose G Miranda; Gopal P Pathak; Robert M Hughes; Chandra L Tucker
Journal:  Nat Chem Biol       Date:  2016-04-11       Impact factor: 15.040

10.  Computational design of chemogenetic and optogenetic split proteins.

Authors:  Onur Dagliyan; Andrey Krokhotin; Irem Ozkan-Dagliyan; Alexander Deiters; Channing J Der; Klaus M Hahn; Nikolay V Dokholyan
Journal:  Nat Commun       Date:  2018-10-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.